Torti Frank
SEC insider (Form 3/4/5 filer). CIK 0001647805. President and Vant Chair at Roivant Sciences Ltd. (ROIV) and 1 other issuer. 16 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in LONDON.
Companies Torti Frank has filed insider reports for
- Roivant Sciences Ltd. (ROIV): Officer, President and Vant Chair
- Immunovant, Inc. (IMVT): Director
Torti Frank
CIK: 0001647805
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Sep 30, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect40.3K shares at avg. $36.57$1.5M - Jun 30, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect40.3K shares at avg. $35.39$1.4M - Apr 7, 2026IMVT
Immunovant, Inc.
AwardDirect174.2K shares- - Mar 31, 2026ROIV
Roivant Sciences Ltd.
Tax PaymentDirect160K shares at avg. $27.70$4.4M - Feb 23, 2026ROIV
Roivant Sciences Ltd.
SaleDirect587.4K shares at avg. $27.51$16.2M - Feb 23, 2026ROIV
Roivant Sciences Ltd.
ExerciseDirect587.4K shares at avg. $3.85$2.3M - Feb 20, 2026ROIV
Roivant Sciences Ltd.
ExerciseDirect1M shares at avg. $3.85$3.9M - Feb 20, 2026ROIV
Roivant Sciences Ltd.
SaleDirect1M shares at avg. $27.15$27.5M - Feb 19, 2026ROIV
Roivant Sciences Ltd.
ExerciseDirect1.4M shares at avg. $3.85$5.4M - Feb 19, 2026ROIV
Roivant Sciences Ltd.
SaleDirect1.4M shares at avg. $27.42$38.4M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  ROIV Roivant Sciences Ltd. | Tax Payment | 40,309 | $36.57 | $1,474,100 | Direct |
| Jun 30, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment | 40,310 | $35.39 | $1,426,571 | Direct |
| Apr 7, 2026 |  IMVT Immunovant, Inc. | Award | 174,189 | - | $0 | Direct |
| Mar 31, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment | 160,035 | $27.70 | $4,432,970 | Direct |
| Feb 23, 2026 | ROIV Roivant Sciences Ltd. | Sale | 587,390 | $27.51 | $16,159,099 | Direct |
| Feb 23, 2026 | ROIV Roivant Sciences Ltd. | Exercise | 587,390 | $3.85 | $2,261,452 | Direct |
| Feb 20, 2026 | ROIV Roivant Sciences Ltd. | Exercise | 1,012,610 | $3.85 | $3,898,549 | Direct |
| Feb 20, 2026 | ROIV Roivant Sciences Ltd. | Sale | 1,012,610 | $27.15 | $27,492,362 | Direct |
| Feb 19, 2026 | ROIV Roivant Sciences Ltd. | Exercise | 1,400,000 | $3.85 | $5,390,000 | Direct |
| Feb 19, 2026 | ROIV Roivant Sciences Ltd. | Sale | 1,400,000 | $27.42 | $38,388,000 | Direct |
1-10 of 16 transactions